Literature DB >> 17349440

Updates in the management of gout.

Michael P Keith1, William R Gilliland.   

Abstract

The majority of patients with gout are cared for by primary care physicians. Although both the physician and patient may easily recognize the acute arthritis of gout, errors in selecting the most appropriate medication and proper dose are common. The clinical stages of gout include asymptomatic hyperuricemia, intermittent gouty arthritis, and chronic tophaceous gout. Treatment of gout is usually considered after the first attack of arthritis, typically podagra. The aims of treatment are to alleviate the pain and inflammation associated with acute attacks, prevent future attacks, and decrease uric acid levels. Confusion frequently arises because certain medications such as colchicine may have dual purposes: to treat an acute attack and to suppress future attacks. The purpose of this management update is to provide practical advice about prescribing the proper medication considering both treatment goals and patient comorbidities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17349440     DOI: 10.1016/j.amjmed.2006.02.044

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  15 in total

1.  [European League Against Rheumatism evidence-based recommendations for diagnosis and management of gout].

Authors:  B Grusch; B Rintelen; B F Leeb
Journal:  Z Rheumatol       Date:  2007-11       Impact factor: 1.372

Review 2.  A middle-aged man with pain and swelling of the hands.

Authors:  Esha Das Gupta
Journal:  Malays Fam Physician       Date:  2007-08-31

3.  Impact of deficits in gout care on hospitalizations.

Authors:  Prachaya Nitichaikulvatana; Katherine S Upchurch; Leslie R Harrold
Journal:  J Clin Rheumatol       Date:  2011-10       Impact factor: 3.517

4.  Anti-nociceptive and anti-edematogenic effects of glibenclamide in a model of acute gouty attack in rats.

Authors:  Rosane M S dos Santos; Sara M Oliveira; Cássia R Silva; Carin Hoffmeister; Juliano Ferreira; Jamil Assreuy
Journal:  Inflamm Res       Date:  2013-03-30       Impact factor: 4.575

Review 5.  Gout tophus on an intradural fascicle: a case description.

Authors:  Nadine Willner; Camelia-Maria Monoranu; Christian Stetter; Ralf-Ingo Ernestus; Thomas Westermaier
Journal:  Eur Spine J       Date:  2015-11-10       Impact factor: 3.134

6.  The dynamics of chronic gout treatment: medication gaps and return to therapy.

Authors:  Leslie R Harrold; Susan E Andrade; Becky Briesacher; Marsha A Raebel; Hassan Fouayzi; Robert A Yood; Ira S Ockene
Journal:  Am J Med       Date:  2010-01       Impact factor: 4.965

7.  Inhibition of Inducible Nitric Oxide Synthase Attenuates Monosodium Urate-induced Inflammation in Mice.

Authors:  Tae-Jin Ju; Jin-Myoung Dan; Young-Je Cho; So-Young Park
Journal:  Korean J Physiol Pharmacol       Date:  2011-12-27       Impact factor: 2.016

8.  Adherence with urate-lowering therapies for the treatment of gout.

Authors:  Leslie R Harrold; Susan E Andrade; Becky A Briesacher; Marsha A Raebel; Hassan Fouayzi; Robert A Yood; Ira S Ockene
Journal:  Arthritis Res Ther       Date:  2009-03-27       Impact factor: 5.156

9.  Imaging appearances in gout.

Authors:  Gandikota Girish; David M Melville; Gurjit S Kaeley; Catherine J Brandon; Janak R Goyal; Jon A Jacobson; David A Jamadar
Journal:  Arthritis       Date:  2013-03-25

10.  Elevated systemic antibodies towards commensal gut microbiota in autoinflammatory condition.

Authors:  Gayane P Manukyan; Karine A Ghazaryan; Zhanna A Ktsoyan; Zaruhi A Khachatryan; Karine A Arakelova; Denise Kelly; George Grant; Rustam I Aminov
Journal:  PLoS One       Date:  2008-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.